These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17230058

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [Abstract] [Full Text] [Related]

  • 26. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
    Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M.
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
    [Abstract] [Full Text] [Related]

  • 27. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M.
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [Abstract] [Full Text] [Related]

  • 28. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP, Shields C, Meadows AT.
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [Abstract] [Full Text] [Related]

  • 29. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y, Zhang X, Liu F, Wang KL.
    Asian Pac J Cancer Prev; 2014 Feb; 15(18):7805-9. PubMed ID: 25292067
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
    Wilson MW, Haik BG, Liu T, Merchant TE, Rodriguez-Galindo C.
    Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [Abstract] [Full Text] [Related]

  • 35. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA.
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [Abstract] [Full Text] [Related]

  • 36. Conservative therapy in intraocular retinoblastoma: response/recurrence rate.
    Schiavetti A, Hadjistilianou T, Clerico A, Bonci E, Ragni G, Castello MA.
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):3-6. PubMed ID: 15654270
    [Abstract] [Full Text] [Related]

  • 37. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 38. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [Abstract] [Full Text] [Related]

  • 39. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 40. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.